- Nachrichtendetail
-
11.07.2024 13:22:34 - dpa-AFX: *PFIZER ADVANCES DEVELOPMENT OF ONCE-DAILY FORMULATION OF ORAL GLP-1 RECEPTOR AGONIST DANUGLIPRON
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Pfizer | 852009 | NYSE | 28,900 | 23.08.24 03:00:45 | +0,120 | +0,42% | 28,900 | 28,930 | 28,820 | 28,900 |
